Creating liberating content

Bangladesh Experiences Modest Growth...

HomeNews & ViewsBusiness FocusBangladesh Experiences Modest Growth in US Apparel Imports Amidst 2024...

Oerlikon Manmade Fibers Solutions...

HomeEventsOerlikon Manmade Fibers Solutions hosted successful Technology Day 2025 in IndiaEventsOerlikon Manmade Fibers...

Ready-Made Garment & Textile...

HomeConversationsReady-Made Garment & Textile Sector: The Change Maker Of Bangladesh EconomyConversationsReady-Made Garment &...

Turkish central bank revises...

The Turkish central bank (CBRT) revised its year-end inflation forecast recently from 21...
Home News India extends compliance timeline for medical textiles QCO

India extends compliance timeline for medical textiles QCO

0
India extends compliance timeline for medical textiles QCO

The Ministry of Textiles, Government of India, has recently amended the Medical Textiles (Quality Control) Order, 2024 (QCO), introducing measures aimed at ensuring compliance while accommodating the needs of Small and Medium Enterprises (SMEs). This step aligns with the government’s vision of promoting safety, efficacy, and consumer confidence in critical medical textiles.

The Ministry of Textiles amended the Medical Textiles (Quality Control) Order, 2024, extending SME compliance to April 1, 2025, for sanitary products, while large enterprises must comply by January 1, 2025.
Manufacturers have until June 30, 2025, to clear old stock.
These steps aim to balance safety standards with support for smaller businesses.

The amendment, now known as the Medical Textiles (Quality Control) Amendment Order, 2025, extends the compliance deadline for SMEs to April 1, 2025, for three key items under Schedule A of the order: sanitary napkins, baby diapers, and reusable sanitary products (e.g., pads, period panties). Large and medium enterprises must adhere to the earlier timeline of January 1, 2025.

In a bid to further ease the transition, manufacturers and importers have been granted a six-month period, up to June 30, 2025, to clear their legacy stock of non-compliant products. This provision allows businesses to align operations with the new regulations while minimising disruptions, Ministry of Textiles said in a media release.

The key amendments include the recognition of old stock products manufactured or imported prior to the implementation timelines, provided they are declared under the Bureau of Indian Standards (BIS) Act, 2016 and adjusting the compliance timeline.

The ministry emphasised that these measures underscore its commitment to strengthening quality standards in the medical textile sector. By balancing regulatory enforcement with practical considerations, particularly for smaller players, the government aims to ensure a seamless adoption of stringent testing protocols, labelling, and safety standards.

Fibre2Fashion News Desk (HU)